Mainly contributing to WP3, WP4, WP6 and WP8 and supporting WP7 and WP9.
BRAVE will contribute to the project by providing on-line measurement technologies for specific particle parameters (e.g. real time aggregation behaviour, concentration, size and size distribution) tailored and measured at process relevant key-particle production locations, providing parameters for process evaluations/optimization.
BRAVE will work together with the Medical University of Graz NM-Lab to mature its proprietary OptoFluidic Force Induction (OF2i) equipment, will implement and further develop process tailored inline and real-time measurement routines. It will test and install OF2i equipment sets for onsite testing in WP 6 and adapt their devices to on site process conditions.
BRAVE will support the OF2i installation to increase product quality and find suitable nano-characterisation routines for production & process control and production reproducibility. It will further support the translation and business development aspirations in WP9 to foster NanoPATÂīs final goal to successfully translate real time nano characterisation technologies towards the market.